HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS

HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS was reported 73 times

HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD38-directed Cytolytic Antibody [EPC] 3 0.0005
1 Complement Inhibitor [EPC] 16 0.0003
2 Glycopeptide Antibacterial [EPC] 16 0.0002
3 Provitamin D2 Compound [EPC] 4 0.0001
4 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0001
5 Carbonic Anhydrase Inhibitor [EPC] 2 0.0001
6 Vascular Endothelial Growth Factor Inhibitor [EPC] 16 0.0001
7 Proteasome Inhibitor [EPC] 7 0.0001
8 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 6 0.0001
9 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 6 0.0001
10 Prostaglandin Analog [EPC] 4 0.0000
11 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
12 Insulin [EPC] 1 0.0000
13 beta3-Adrenergic Agonist [EPC] 1 0.0000
14 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
15 Corticosteroid [EPC] 20 0.0000
16 Thalidomide Analog [EPC] 7 0.0000
17 Alkylating Drug [EPC] 3 0.0000
18 Loop Diuretic [EPC] 5 0.0000
19 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
20 Fluoroquinolone Antibacterial [EPC] 1 0.0000
21 Factor Xa Inhibitor [EPC] 2 0.0000
22 alpha-Adrenergic Blocker [EPC] 1 0.0000
23 Calcium [EPC] 1 0.0000
24 beta-Adrenergic Blocker [EPC] 2 0.0000
25 Aldosterone Antagonist [EPC] 1 0.0000
26 Platelet Aggregation Inhibitor [EPC] 3 0.0000
27 Insulin Analog [EPC] 2 0.0000
28 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
29 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
30 GLP-1 Receptor Agonist [EPC] 1 0.0000
31 Kinase Inhibitor [EPC] 1 0.0000
32 Proton Pump Inhibitor [EPC] 1 0.0000